Primary Aldosteronism
114
42
47
39
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 114 trials
100.0%
+13.5% vs benchmark
9%
10 trials in Phase 3/4
8%
3 of 39 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 39 completed trials
Clinical Trials (114)
EndoSense: Continuous Real-Time Monitoring of Health Markers in Endocrine and Metabolic Disorders
Randomised Trial Comparing Thermal Ablation With Adrenalectomy in the Treatment of Unilateral Asymmetric PA
A Novel and Efficient Biochemical Screening Strategy for Glucocorticoid-Remediable Aldosteronism: Combined 1-mg Overnight Dexamethasone Suppression Test and Steroid Profile
Endoscopic Ultrasound-Guided Ethanol Ablation for Aldosterone-Producing Adenoma
Study on the Application of Liquid Chromatography-Tandem Mass Spectrometry for the Determination of Aldosterone and Renin Activity in the Diagnosis of Primary Aldosteronism by Captopril Test
Efficacy and Safety of Finerenone Compared to Spironolactone in Treatment of Primary Aldosteronism
Intensive vs. Standard Blood Pressure Control in Primary Aldosteronism
Diagnosing Variable Primary Aldosteronism.
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Primary Aldosteronism
Study on the Diagnostic Cut-off Point of 24-hour Urinary Aldosterone Measured by Liquid Chromatography-Tandem Mass Spectrometry in the Diagnosis of Primary Aldosteronism in the Oral Sodium Loading Test
Study on Cutoff Revision Effects and Evaluation of NNT in Primary Aldosteronism
Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism
Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism
Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism Patients Concurrent With or Without Autonomous Cortisol Secretion
A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With Primary Aldosteronism
Steroids-Based Screening for Primary Aldosteronism
Study of QLS1410 in the Treatment of Primary Aldosteronism.
REnin-guided TherApy With MinEralocorticoid Receptor Antagonists in Primary Aldosteronism - Feasibility Study
A Study of CIN-107 in Adults With Primary Aldosteronism
Aldosterone Renin Ratio (ARR) Test to Increase Case-detection of Primary Aldosteronism (PA)